Mitrade Insights is dedicated to providing investors with rich, timely and most valuable financial information to help investors grasp the market situation and find timely trading opportunities.

2021

Best News & Analysis Provider

FxDailyInfo

2022

Best Forex Educational Resources Global

International Business Magazine

Insights

News

Cryptocurrencies

Based on the AI Tech, Web3 DID platform Genomefi was built with a strategy partnership with Genomics.

Source Livebitcoinnews

Based on Artificial intelligence, the web 3 DID platform GenomeFi announced the strategy partnership with Genomics on 15 April.

Both Corporations will collaborate on Genome ecosystem expansion. The companies will expand their platform services, plan and launch genome-based products, and develop marketing strategies to attract domestic and global users.

GenomeFI is a blockchain foundation that uses artificial intelligence analysis technology to build genetic big data. It strives to expand genome content and build an incentive system using blockchain technology. GenomeFi Foundation plans to launch a Genomic Decentralized Identity (GDID) service, which allows individual NFTs based on personal genetic information to be issued and used as an identity verification tool by users

“Geromics is a bio specialist company that aims to solve extreme aging and diseases based on artificial intelligence and biotechnology. Recently, it signed a technology transfer agreement with Invitesgenomics about the seven technology patents related to the cancer vaccine platform “Neoantigen Cancer Vaccine Prediction Technology” and agreed to cooperate in developing personalized cancer vaccine therapies. Based on this, Geromics aims to develop and commercialize platform technologies to overcome aging and diseases in the long term.”

“Jimmy Choi, CEO of GenomeFi, said, ‘We plan to collaborate with excellent biotechnology companies and institutions to expand the bio ecosystem and popularize genome content.’ He added, ‘We will work together with Geromics not only for the expansion of the bio ecosystem but also for security and technical cooperation in all areas.”

The post Based on the AI Tech, Web3 DID platform Genomefi was built with a strategy partnership with Genomics. appeared first on Live Bitcoin News.

Disclaimer: For information purposes only. Past performance is not indicative of future results.

Recommended Articles

Tesla jumps 5% as Barclays puts a $450 target on the SpaceX merger — the chart was already pointing to 431 Tesla closed at $391.62 on October 26, up 5.21%, after Barclays upgraded the stock to Overweight and lifted its target to $450 from $370, citing a sharp inflection in Robotaxi miles and a potential SpaceX merger. The move also completed a double bottom at $345.88 and $349.33, with a neckline at $388.56 and a measured target of $431.24. Here is what the upgrade actually says, why the chart and the analyst now point the same way, and what would break the target.

Author Irene Q.

Oct 27, Tue

Tesla closed at $391.62 on October 26, up 5.21%, after Barclays upgraded the stock to Overweight and lifted its target to $450 from $370, citing a sharp inflection in Robotaxi miles and a potential SpaceX merger. The move also completed a double bottom at $345.88 and $349.33, with a neckline at $388.56 and a measured target of $431.24. Here is what the upgrade actually says, why the chart and the analyst now point the same way, and what would break the target.

Brent's $115 front month sits $4.6 above January — the $14 spread to WTI is the supply-risk premium December Brent trades at $115.29 while January is $110.71, a $4.58 backwardation. The December Brent-WTI spread is $14.2, versus a $3-5 normal. That gap, not the headline, is where the Middle East supply risk is priced. Here is what the curve says, why the December contract's expiry on October 30 will mechanically cut the headline by $4.6, and the 108.81 neckline that decides the next move.

Author Irene Q.

Oct 28, Wed

December Brent trades at $115.29 while January is $110.71, a $4.58 backwardation. The December Brent-WTI spread is $14.2, versus a $3-5 normal. That gap, not the headline, is where the Middle East supply risk is priced. Here is what the curve says, why the December contract's expiry on October 30 will mechanically cut the headline by $4.6, and the 108.81 neckline that decides the next move.

The Fed held at 3.75%–4.00% — and two officials voted to hike. December is now 85% priced The FOMC held by a 10–2 vote, with Governor Cook and Cleveland Fed President Hammack dissenting for a 25bp hike. Chair Warsh offered no forward guidance and no dot plot, the 2-year yield fell 8bp to 4.70%, and the dollar slipped to 101.84 even as markets moved December hike odds to 85%–87%. Tonight's Q3 GDP and September core PCE are the next referee.

Author Irene Q.

Oct 29, Thu

The FOMC held by a 10–2 vote, with Governor Cook and Cleveland Fed President Hammack dissenting for a 25bp hike. Chair Warsh offered no forward guidance and no dot plot, the 2-year yield fell 8bp to 4.70%, and the dollar slipped to 101.84 even as markets moved December hike odds to 85%–87%. Tonight's Q3 GDP and September core PCE are the next referee.

Gold Price Analysis Today | Forex Gold Analysis | XAU/USD Analysis - October 30, 2026 Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for October 30, 2026. Read on for the details.

Author Mitrade

Oct 30, Fri

Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for October 30, 2026. Read on for the details.

US GDP grew 3.4% and core PCE held at 3.1% — December is now a hike trade, not a cut trade US Q3 GDP rose 3.4%, above the 3.1% estimate, while September headline PCE hit 3.6% and core held at 3.1%. December hike odds are near 90%; inventories, AI capex and energy explain why.

Author Irene Q.

Oct 30, Fri

US Q3 GDP rose 3.4%, above the 3.1% estimate, while September headline PCE hit 3.6% and core held at 3.1%. December hike odds are near 90%; inventories, AI capex and energy explain why.

Popular Symbols